229 related articles for article (PubMed ID: 34010422)
1. The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Kosari K; Agopian VG; Rich NE; Lu SC; Tseng HR; Nissen NN; Singal AG; Yang JD
J Natl Cancer Inst; 2021 Nov; 113(11):1531-1541. PubMed ID: 34010422
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends.
Wang J; Li E; Yang H; Wu J; Lu HC; Yi C; Lei J; Liao W; Wu L
World J Surg Oncol; 2019 Feb; 17(1):43. PubMed ID: 30813932
[TBL] [Abstract][Full Text] [Related]
4. Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study.
Yao J; Liang X; Liu Y; Li S; Zheng M
Cancer Control; 2022; 29():10732748211051548. PubMed ID: 35147456
[TBL] [Abstract][Full Text] [Related]
5. Have incidence rates of liver cancer peaked in the United States?
Petrick JL; Florio AA; Loomba R; McGlynn KA
Cancer; 2020 Jul; 126(13):3151-3155. PubMed ID: 32294255
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
[TBL] [Abstract][Full Text] [Related]
7. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
[TBL] [Abstract][Full Text] [Related]
8. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.
McGlynn KA; Tarone RE; El-Serag HB
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1198-203. PubMed ID: 16775181
[TBL] [Abstract][Full Text] [Related]
9. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
[TBL] [Abstract][Full Text] [Related]
10. Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.
Petrick JL; Freedman ND; Graubard BI; Sahasrabuddhe VV; Lai GY; Alavanja MC; Beane-Freeman LE; Boggs DA; Buring JE; Chan AT; Chong DQ; Fuchs CS; Gapstur SM; Gaziano JM; Giovannucci EL; Hollenbeck AR; King LY; Koshiol J; Lee IM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Schairer C; Sesso HD; Sigurdson AJ; Zeleniuch-Jacquotte A; Wactawski-Wende J; Campbell PT; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1398-406. PubMed ID: 26126626
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
[TBL] [Abstract][Full Text] [Related]
12. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.
Jarnagin WR; Weber S; Tickoo SK; Koea JB; Obiekwe S; Fong Y; DeMatteo RP; Blumgart LH; Klimstra D
Cancer; 2002 Apr; 94(7):2040-6. PubMed ID: 11932907
[TBL] [Abstract][Full Text] [Related]
13. Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021.
Kim D; Manikat R; Cholankeril G; Ahmed A
Liver Int; 2023 Sep; 43(9):1865-1870. PubMed ID: 37387517
[TBL] [Abstract][Full Text] [Related]
14. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
[TBL] [Abstract][Full Text] [Related]
15. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
[TBL] [Abstract][Full Text] [Related]
17. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.
Patel T
Hepatology; 2001 Jun; 33(6):1353-7. PubMed ID: 11391522
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
